课题基金 / 基金详情

Ex Vivo Treatment of Latent Human Cytomegalovirus in Donor Lungs Using F49A-Fusion Protein: Pre-Clinical Studies and a Safety Pilot Clinical Trial.

Ex Vivo Treatment of Latent Human Cytomegalovirus in Donor Lungs Using F49A-Fusion Protein: Pre-Clinical Studies and a Safety Pilot Clinical Trial.
使用 F49A 融合蛋白离体治疗供体肺中潜伏的人类巨细胞病毒:临床前研究和安全试点临床试验。
批准号:
435335
负责人:
Cypel Marcelo
金额:
$46.53万
依托单位国家:
加拿大
项目类别:
Operating Grants
财政年份:
2020
资助国家:
加拿大
项目状态:
已结题
起止时间:
2020-10-01 至 2024-10-01

项目摘要

项目成果

Cypel Marcelo的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Lung transplantation is a life-saving intervention for people with advanced lung diseases. However, because transplant recipients have their immune system medically depleted, they are at a significant risk of acquiring viruses carried by the transplanted
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Evaluation of 10°C as an optimal temperature for cold static lung preservation: A randomized controlled trial
  • 批准号:
    462951
  • 项目类别:
    Operating Grants
  • 资助金额:
    $35.67万
  • 财政年份:
    2022
  • 负责人:
    Cypel Marcelo
  • 依托单位:
Establishing strategies to preserve donor lungs for multiple days: Cyclic Normothermic Ex vivo Lung Perfusion and Mitochondrial Transplantation .
  • 批准号:
    434839
  • 项目类别:
    Operating Grants
  • 资助金额:
    $58.52万
  • 财政年份:
    2020
  • 负责人:
    Cypel Marcelo
  • 依托单位:
Transplantation of Hepatitis C infected donors to negative recipients: Combining donor and recipient strategies to prevent transmission.
  • 批准号:
    403566
  • 项目类别:
    Operating Grants
  • 资助金额:
    $35.11万
  • 财政年份:
    2019
  • 负责人:
    Cypel Marcelo
  • 依托单位:
Lung Transplantation using Hepatitis C Positive Donors to Hepatitis C Negative Recipients: A Safety Trial
  • 批准号:
    358469
  • 项目类别:
    Operating Grants
  • 资助金额:
    $44.58万
  • 财政年份:
    2016
  • 负责人:
    Cypel Marcelo
  • 依托单位:
海外基金